France says ‘unacceptable’ for U.S. to get Sanofi vaccine first
Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be "unacceptable,” a French government minister said. "For us, it would be unacceptable that there be privileged access for this or that country on a pretext that would be a financial ...
Takeda's dengue vaccine said effective overall in study but with major limitation
Takeda Pharmaceutical Co.'s experimental dengue vaccine was highly effective at preventing the mosquito-borne disease in a late stage study, but it failed to protect against one type of the virus in people with no prior exposure to dengue. Takeda's vaccine was 80.2 percent effective at ...
FDA investigating heartburn drug Zantac for carcinogen risks
The U.S. Food and Drug Administration is investigating whether the popular heartburn drug Zantac causes carcinogens to form in the bodies of users, in an effort to fully understand the risks posed by the already recalled drug, the agency's spokesman said on Thursday. The issue ...
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year. Takeda Pharmaceutical Co. plans to seek approval for the experimental vaccine first in countries where the virus is endemic, ...
Takeda dengue vaccine meets main goal of trial; detailed results to come
Takeda Pharmaceutical Co. said Tuesday that its experimental dengue vaccine appears to be safe and effective at preventing all four types of the mosquito-borne disease, meeting the main goal of the drugmaker's late-stage clinical trial. The company said no significant safety concerns have emerged to ...
Philippines snubbed advice of experts to tread incrementally in pursuing child dengue immunizations
As she announced in January 2016 that the Philippines would immunize 1 million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research. At the time, it seemed ...
U.S. Army, France's Sanofi to speed effort to develop Zika vaccine
French drugmaker Sanofi said on Wednesday it had struck a research and development deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus. Sanofi is the only major drugmaker working on a vaccine against Zika, which has ...
Japanese drugmaker SSP Co. will be put under the wing of Sanofi as the French health care titan and Germany's Boehringer Ingelheim GmbH announced an asset swap agreement Monday. Under the deal, Sanofi will acquire Boehringer's consumer health operation, including SSP, in exchange for its ...
Zika poses Asia, Oceania, South Europe threat; Sanofi joins race for viable vaccine
The Zika virus could spread to Africa, Asia and Southern Europe, the World Health Organization said on Tuesday, as major French drugmaker Sanofi SA and others joined the race to create a vaccine. A day after Geneva-based WHO declared an international public health emergency due ...
Mexico approves world's first dengue vaccine after 20 years of research
The first vaccine against dengue fever won clearance in Mexico, an initial step toward preventing a mosquito-borne infection that puts half of the world's population at risk. Sanofi expects more approvals in "upcoming weeks" for the product, called Dengvaxia, in Latin America and Asia, Olivier ...
Mosquito-borne dengue targeted by antibody with hope for vaccine
Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year. The antibodies are effective against all four dengue viruses, according to an article published ...
